Scholar Rock’s investigational spinal muscular atrophy drug helped patients taking Eli Lilly’s obesity blockbuster Zepbound ...

Approximately 15 million Americans are on a GPL-1 or better known as Ozempic, Wegovy and Zepbound but there will be upcoming changes at CVS that may make getting the drug harder and pricier. Scripta ...

Clinical trial participants who took Zepbound lost an average of 50 pounds over 72 weeks, while those who took Wegovy lost about 33 pounds. ... Official Release Date Trailer.

Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. 1 Zepbound Self Pay Journey Program lowers the price of ...

Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...

People who have frequent nightmares appear to have a tripled risk of premature death, according to a new study.

Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release. 1 Zepbound Self Pay Journey Program lowers the price of ...

In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...

Eli Lilly and Company (NYSE:LLY) is one of Best Dividend Stocks to Buy for Dependable Dividend Growth. According to Adam ...